Urban S, Zieseniss S, Werder M, Hauser H, Budzinski R, Engelmann B
Physiologisches Institut der Universität München, Schillerstrasse 44, 80336 München, Germany.
J Biol Chem. 2000 Oct 27;275(43):33409-15. doi: 10.1074/jbc.M004031200.
The phospholipids of lipoproteins can be transferred to cells by an endocytosis-independent uptake pathway. We analyzed the role of scavenger receptor BI (SR-BI) for the selective cellular phospholipid import. Human monocytes rapidly acquired the pyrene (py)-labeled phospholipids sphingomyelin (SM), phosphatidylcholine, and phosphatidylethanolamine from different donors (low and high density lipoproteins (LDL, HDL), lipid vesicles). The anti-SR-BI antibody directed against the extracellular loop of the membrane protein lowered the cellular import of the phospholipids by 40-80%. The phospholipid transfer from the lipid vesicles into the monocytes was suppressed by LDL, HDL, and apoprotein AI. Transfection of BHK cells with the cDNA for human SR-BI enhanced the cellular import of the vesicle-derived py-phospholipids by 5-6-fold. In the case of the LDL donors, transfer of py-SM to the transfected cells was stimulated to a greater extent than the uptake of the other py-phospholipids. Similar differences were not observed when the vesicles and HDL were used as phospholipid donors. The concentration of LDL required for the half-maximal phospholipid import was close to the previously reported apparent dissociation constant for LDL binding to SR-BI. The low activation energy of the SR-BI-mediated py-phospholipid import indicated that the transfer occurs entirely in a hydrophobic environment. Disruption of cell membrane caveolae by cyclodextrin treatment reduced the SR-BI-catalyzed incorporation of py-SM, suggesting that intact caveolae are necessary for the phospholipid uptake. In conclusion, SR-BI mediates the selective import of the major lipoprotein-associated phospholipids into the cells, the transfer efficiency being dependent on the structure of the donor lipoprotein.
脂蛋白的磷脂可通过一种不依赖内吞作用的摄取途径转移至细胞。我们分析了清道夫受体BI(SR-BI)在细胞选择性摄取磷脂中的作用。人单核细胞能快速从不同供体(低密度脂蛋白和高密度脂蛋白(LDL、HDL)、脂质囊泡)摄取芘(py)标记的磷脂鞘磷脂(SM)、磷脂酰胆碱和磷脂酰乙醇胺。针对该膜蛋白细胞外环的抗SR-BI抗体使磷脂的细胞摄取量降低了40%-80%。LDL、HDL和载脂蛋白AI抑制了磷脂从脂质囊泡向单核细胞的转移。用人类SR-BI的cDNA转染BHK细胞,可使源自囊泡的py-磷脂的细胞摄取量提高5-6倍。对于LDL供体,py-SM向转染细胞的转移比其他py-磷脂的摄取受到的刺激更大。当使用囊泡和HDL作为磷脂供体时,未观察到类似差异。使磷脂摄取量达到半数最大值所需的LDL浓度接近先前报道的LDL与SR-BI结合的表观解离常数。SR-BI介导的py-磷脂摄取的低活化能表明该转移完全发生在疏水环境中。用环糊精处理破坏细胞膜小窝会降低SR-BI催化的py-SM掺入,这表明完整的小窝对于磷脂摄取是必需的。总之,SR-BI介导主要脂蛋白相关磷脂向细胞的选择性摄取,转移效率取决于供体脂蛋白的结构。